BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29052492)

  • 1. Systematic review and meta-analysis of secondary prophylaxis for prevention of HIV-related toxoplasmic encephalitis relapse using trimethoprim-sulfamethoxazole.
    Connolly MP; Haitsma G; Hernández AV; Vidal JE
    Pathog Glob Health; 2017 Sep; 111(6):327-331. PubMed ID: 29052492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis.
    Connolly MP; Goodwin E; Schey C; Zummo J
    Pathog Glob Health; 2017 Feb; 111(1):31-44. PubMed ID: 28090819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients.
    Yan J; Huang B; Liu G; Wu B; Huang S; Zheng H; Shen J; Lun ZR; Wang Y; Lu F
    Acta Trop; 2013 Sep; 127(3):236-44. PubMed ID: 23707647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
    Hernandez AV; Thota P; Pellegrino D; Pasupuleti V; Benites-Zapata VA; Deshpande A; Penalva de Oliveira AC; Vidal JE
    HIV Med; 2017 Feb; 18(2):115-124. PubMed ID: 27353303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings).
    Dedicoat M; Livesley N
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005420. PubMed ID: 16856096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the Evidence Base for Modern-Day Practice of the Treatment of Toxoplasmic Encephalitis: A Systematic Review and Meta-Analysis.
    Prosty C; Hanula R; Levin Y; Bogoch II; McDonald EG; Lee TC
    Clin Infect Dis; 2023 Feb; 76(3):e1302-e1319. PubMed ID: 35944134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
    Fisher RG; Nageswaran S; Valentine ME; McKinney RE
    AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis.
    Monti S; Delvino P; Riboli M; Rebuffi C; Xoxi B; De Silvestri A; Montecucco C
    Rheumatology (Oxford); 2021 Aug; 60(8):3553-3564. PubMed ID: 33752235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasmic encephalitis in HIV-infected persons: risk factors and trends. The Adult/Adolescent Spectrum of Disease Group.
    Jones JL; Hanson DL; Chu SY; Ciesielski CA; Kaplan JE; Ward JW; Navin TR
    AIDS; 1996 Oct; 10(12):1393-9. PubMed ID: 8902069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy.
    Duval X; Pajot O; Le Moing V; Longuet P; Ecobichon JL; Mentre F; Leport C; Vilde JL
    AIDS; 2004 Jun; 18(9):1342-4. PubMed ID: 15362670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization to trimethoprim-sulfamethoxazole in a toxoplasmic encephalitis patient who was intolerant to conventional treatments.
    Miyata N; Yoshimura Y; Hikosaka K; Norose K; Tachikawa N
    J Infect Chemother; 2020 Mar; 26(3):289-293. PubMed ID: 31711832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does trimethoprim-sulfamethoxazole prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a systematic review.
    Sibanda EL; Weller IV; Hakim JG; Cowan FM
    Clin Infect Dis; 2011 May; 52(9):1184-94. PubMed ID: 21467024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.
    Buijs BS; van den Berk GE; Boateng CP; Hoepelman AI; van Maarseveen EM; Arends JE
    AIDS; 2015 Apr; 29(7):785-91. PubMed ID: 25985401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006.
    Béraud G; Pierre-François S; Foltzer A; Abel S; Liautaud B; Smadja D; Cabié A
    Am J Trop Med Hyg; 2009 Apr; 80(4):583-7. PubMed ID: 19346380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotrimoxazole is effective as primary prophylaxis for toxoplasmic encephalitis in HIV-infected patients: a case control study.
    Weigel HM; de Vries E; Regez RM; Henrichs JH; Ten Velden JJ; Frissen PH; van der Meer JT
    Scand J Infect Dis; 1997; 29(5):499-502. PubMed ID: 9435040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
    Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
    Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017.
    Belk K; Connolly MP; Schlesinger L; Ben-Harari RR
    Pathog Glob Health; 2018 Dec; 112(8):428-437. PubMed ID: 30526421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study.
    Kohli R; Lo Y; Homel P; Flanigan TP; Gardner LI; Howard AA; Rompalo AM; Moskaleva G; Schuman P; Schoenbaum EE;
    Clin Infect Dis; 2006 Jul; 43(1):90-8. PubMed ID: 16758423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.